The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 1 study of the MDM2 inhibitor DS-3032b in patients (pts) with advanced solid tumors and lymphomas.
 
Mrinal M. Gounder
Consulting or Advisory Role - Amgen; Daiichi Sankyo
Travel, Accommodations, Expenses - Amgen; Daiichi Sankyo
 
Todd Michael Bauer
No Relationships to Disclose
 
Gary K. Schwartz
Honoraria - AstraZeneca; Boehringer Ingelheim; Daiichi Sankyo; Novartis
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Daiichi Sankyo; Novartis
Patents, Royalties, Other Intellectual Property - Patent pending regarding development of PNAs for targeted cancer therapy (new technology)
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Daiichi Sankyo; Novartis
 
Tyler Masters
No Relationships to Disclose
 
Richard D. Carvajal
Consulting or Advisory Role - AstraZeneca; Aura Biosciences; Genentech; Iconic Therapeutics; Janssen Biotech; Merck; Novartis; Thomson Reuters
Research Funding - Amgen (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Celldex (Inst); Daiichi Sankyo (Inst); Genentech (Inst); Immunocore (Inst); Incyte (Inst); Lilly (Inst); Merck (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Regeneron (Inst)
 
Saeheum Song
Employment - Daiichi Sankyo
Stock and Other Ownership Interests - Daiichi Sankyo
Travel, Accommodations, Expenses - Daiichi Sankyo
 
Prasanna Kumar
Employment - Daiichi Sankyo
Stock and Other Ownership Interests - Daiichi Sankyo
 
Roohi Gajee
No Relationships to Disclose
 
Oleg Zernovak
Employment - Daiichi Sankyo
Stock and Other Ownership Interests - Daiichi Sankyo, Novartis, Merck
Travel, Accommodations, Expenses - Daiichi Sankyo
 
Michael M. Rosen
Employment - Daiichi Sankyo
Stock and Other Ownership Interests - Allergan; Merck; Pfizer
 
Jarema Peter Kochan
Employment - Daiichi Sankyo
Stock and Other Ownership Interests - Daiichi Sankyo
 
Shuquan Chen
Employment - Daiichi Sankyo
Stock and Other Ownership Interests - Daiichi Sankyo
 
David Michael Hyman
Consulting or Advisory Role - Atara Biotherapeutics
Research Funding - AstraZeneca; Puma Biotechnology
Travel, Accommodations, Expenses - AstraZeneca; Genentech; Puma Biotechnology
 
Sugun Gokmen
Employment - Bellerophon Theraeutics (I); Daiichi Sankyo
Stock and Other Ownership Interests - Bellerophon Theraeutics (I)
 
Funda Meric-Bernstam
Honoraria - Genentech; Roche
Consulting or Advisory Role - Celgene; Genentech; Inflection Biosciences; Novartis; Roche
Research Funding - Aileron Therapeutics; AstraZeneca; Bayer; Calithera Biosciences; CytomX Therapeutics; Debiopharm Group; Genentech; Novartis; PUMA Biotechnology; Taiho Pharmaceutical; Verastem
 
Patricia LoRusso
Consulting or Advisory Role - Astellas Pharma; Astex Pharmaceuticals; Genentech; Novartis
Speakers' Bureau - Genentech
Research Funding - Genentech (Inst); Immunogen (Inst); Merrimack (Inst); Novartis (Inst); Taiho Pharmaceutical (Inst); Tensha Therapeutics (Inst)
 
Neeta Somaiah
Honoraria - Immune Design
Travel, Accommodations, Expenses - Immune Design
 
Amy M. Weise
No Relationships to Disclose
 
David S. Hong
Research Funding - Amgen; Daiichi Sankyo; Eisai; Genentech; Lilly; Merck; Mirati Therapeutics; miRNA Therapeutics; Novartis; Pfizer
Travel, Accommodations, Expenses - Loxo; miRNA Therapeutics